Table 2 Cox regression model eGFR hazard ratios for all-cause and CVD mortality among patients with type 2 diabetes stratified by age using 65 years as cut-off and gender, with eGFR between 90 and 119 mL/min per 1.73 m2 as reference (N = 36,556; years 2013–2019)
eGFR categories (mL/min per 1.73 m2) | < 65 years | ≥65 years | ||||||
|---|---|---|---|---|---|---|---|---|
Number of Deaths (incidence rate (%) Malea) | Hazard Ratio (95% CI) Male | Number of Deaths (incidence rate (%) Femalea) | Hazard Ratio (95% CI) Female | Number of Deaths (incidence rate (%) Malea) | Hazard Ratio (95% CI) Male | Number of Deaths (incidence rate (%) Femalea) | Hazard Ratio (95% CI) Female | |
All-cause mortality | ||||||||
< 30 | 2 (31.25) | 6.63 (1.64, 26.70) | 5 (64.94) | 22.88 (9.36, 55.94) | 32 (66.12) | 4.19 (2.86, 6.13) | 42 (51.92) | 6.90 (4.89, 9.74) |
30 - < 60 | 17 (7.13) | 1.44 (0.88, 2.38) | 18 (9.23) | 3.01 (1.84, 4.94) | 333 (33.89) | 2.05 (1.69, 2.47) | 270 (23.65) | 3.03 (2.47, 3.71) |
60 - < 90 | 103 (5.54) | 1.12 (0.88, 1.43) | 53 (5.17) | 1.68 (1.22, 2.32) | 536 (20.19) | 1.20 (1.00, 1.44) | 489 (16.30) | 2.06 (1.71, 2.49) |
90 - < 120 | 172 (4.95) | 1.00 (Reference) | 127 (3.08) | 1.00 (Reference) | 152 (16.90) | 1.00 (Reference) | 141 (7.99) | 1.00 (Reference) |
CVD mortality | ||||||||
< 30 | 1 (15.63) | 9.58 (1.33, 69.14) | 3 (38.96) | 59.64 (18.16, 195.91) | 9 (18.60) | 4.72 (2.28, 9.79) | 17 (21.01) | 14.43 (7.87, 26.48) |
30 - < 60 | 8 (3.35) | 1.98 (0.95, 4.15) | 7 (3.59) | 5.13 (2.25, 11.71) | 95 (9.67) | 2.38 (1.63, 3.48) | 88 (7.71) | 5.13 (3.33, 7.89) |
60 - < 90 | 37 (1.99) | 1.17 (0.78, 1.77) | 12 (1.17) | 1.67 (0.85, 3.27) | 143 (5.39) | 1.31 (0.91, 1.88) | 118 (3.93) | 2.59 (1.71, 3.94) |
90 - < 120 | 59 (1.70) | 1.00 (Reference) | 29 (0.70) | 1.00 (Reference) | 37 (4.11) | 1.00 (Reference) | 27 (1.53) | 1.00 (Reference) |